retatrutide phase 2 obesity trial results Weight loss with as compared to licenced Retatrutide hits 28% weight loss
Description
302 : R1365R1371
Honka H, Koffert J, Hannukainen JC, Tuulari JJ, Karlsson HK, Immonen H, Oikonen V, Tolvanen T, Soinio M, Salminen P, Kudomi N, Mari A, Iozzo P, Nuutila P
Value cost predictability
A 3-way ANOVA was performed with Tukey multiple comparisons testing
In another study, people taking Contrave lost an average of 510% of their body weight over 12 months when the medicine was combined with a healthy diet and regular exercise
